Embody vs AVARA Rx
A promotional rate against a rate that needs a code.
Embody
Editorial
$79/mo
Embody shows $79 a month for compounded semaglutide and $129 for compounded tirzepatide, both struck through from higher anchors, and both reached by a promotion applied automatically at checkout. Its terms list $199 a month. The oral preparations are priced separately at $229 and $329.
Pick it for: Readers who will read past the promotional rate to the listed one
AVARA Rx
Editorial
$229/mo
AVARA Rx publishes compounded tirzepatide at $279 a month, or $229 with a discount code, and compounded semaglutide at $229 with no code attached. The provider consult and free shipping are stated as included in both figures, and no insurance is required. A code is a condition rather than a price, so $279 is the tirzepatide figure to budget against.
Pick it for: Readers who have the code and will check it still applies
Our verdict
Embody's low figure is promotional and it lists a higher standing rate beside it. Avara Rx's lower figure requires a code. In both cases the advertised number is conditional.
What actually separates them
Embody and AVARA Rx state different things about published price. Everything else they publish, they publish the same way.
AVARA Rx costs $150 more than Embody — 190% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $948 at Embody against $2,748 at AVARA Rx — a difference of $1,800.
| Embody | AVARA Rx | |
|---|---|---|
| Published price | $79/mo | $229/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.